Picture of Sandoz AG logo

SDZ Sandoz AG Share Price

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Momentum

Relative Strength (%)
1m+13.66%
3m-2.12%
6m+4.47%
1yrn/a
Volume Change (%)
10d/3m+62.12%
Price vs... (%)
52w High-5.12%
50d MA+7.58%
200d MA+9.87%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)11.53
PEG Ratio (f)4.53
EPS Growth (f)2.61%
Dividend Yield (f)2.15%
Valuation (ttm)IndustryMarket
Price to Book Value1.64
Price to Tang. Book1.64
Price to Free Cashflown/a
Price to Sales1.42
EV to EBITDA20.77

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital2.73%
Return on Equity0.89%
Operating Margin3.76%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$mn/a9,6589,6789,3069,97910,281.5710,932.551.1%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/a-6.37-0.89+9.63-4.29+17.71n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Sandoz AG EPS forecast chart

Profile Summary

Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    January 17th, 2022
    Public Since
    October 4th, 2023
    No. of Shareholders
    159,809
    No. of Employees
    23,848
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    ch flag iconSIX Swiss Exchange
    Shares in Issue
    429,929,246

    SDZ Share Price Performance

    Upcoming Events for SDZ

    Dividend For SDZNY.PK - 0.4984 USD

    Dividend For SDZ.S - 0.4500 CHF

    Similar to SDZ

    Picture of Cosmo Pharmaceuticals NV logo

    Cosmo Pharmaceuticals NV

    ch flag iconSIX Swiss Exchange

    Picture of Dottikon Es Holding AG logo

    Dottikon Es Holding AG

    ch flag iconSIX Swiss Exchange

    Picture of Galenica AG logo

    Galenica AG

    ch flag iconSIX Swiss Exchange

    Picture of Newron Pharmaceuticals SpA logo

    Newron Pharmaceuticals SpA

    ch flag iconSIX Swiss Exchange

    Picture of Novartis AG logo

    Novartis AG

    ch flag iconSIX Swiss Exchange

    FAQ